We wish to inform you that the Board of Directors at their meeting held on 08.08.2025 had inter alia approved: 1. Un-audited Financial Results for the quarter ended 30.06.2025. 2. Limited ....
KOVAI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Kovai Medical Center & Hospital (KMCH) met on 8 August 2025 and approved the un-audited standalone financial results for Q1 FY26 (quarter ended 30 June 2025), along with the Limited Review Report by statutory auditor VKS Aiyer & Co. Revenue from operations rose to ₹37,359 lakhs, up about 18.7% from ₹31,475 lakhs in Q1 FY25. Total income stood at ₹37,960 lakhs versus ₹32,024 lakhs. Profit before tax grew to ₹7,638 lakhs (vs ₹6,071 lakhs, +25.8% YoY) and profit after tax rose to ₹5,723 lakhs (vs ₹4,575 lakhs, ~25.1% YoY). Basic/diluted EPS came in at ₹52.30 versus ₹41.81 in the year-ago quarter. The auditor issued a clean (unqualified) limited review report with no qualifications, emphasis of matter, or going concern flag.
Strong quarter for KMCH with healthy double-digit revenue growth and roughly 25% YoY jump in profits, reflecting operating leverage from its hospital and education segments. Margin expansion signals improving efficiency, likely to be viewed positively by investors; no negative audit observations.